120 related articles for article (PubMed ID: 36861936)
1. PPARG, GNG12, and CD19 are potential independent predictors of central nerve recurrence in childhood acute lymphoblastic leukemia.
Zhang S; Tu Y; Lai H; Chen H; Tu H; Li J
Hematology; 2023 Dec; 28(1):2182169. PubMed ID: 36861936
[TBL] [Abstract][Full Text] [Related]
2. [Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study].
Chinese Children′s Cancer Group Acute Lymphoblastic Leukemia 2015 Study Group
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1002-1010. PubMed ID: 36207846
[No Abstract] [Full Text] [Related]
3. CD4
Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
Bürger B; Zimmermann M; Mann G; Kühl J; Löning L; Riehm H; Reiter A; Schrappe M
J Clin Oncol; 2003 Jan; 21(2):184-8. PubMed ID: 12525508
[TBL] [Abstract][Full Text] [Related]
5. CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.
Leahy AB; Newman H; Li Y; Liu H; Myers R; DiNofia A; Dolan JG; Callahan C; Baniewicz D; Devine K; Wray L; Aplenc R; June CH; Grupp SA; Rheingold SR; Maude SL
Lancet Haematol; 2021 Oct; 8(10):e711-e722. PubMed ID: 34560014
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia.
Bárcenas-López DA; Núñez-Enríquez JC; Hidalgo-Miranda A; Beltrán-Anaya FO; May-Hau DI; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Medina-Sansón A; Tamez-Gómez EL; López-García VH; Lara-Ramos JR; Núñez-Villegas NN; Peñaloza-González JG; Flores-Villegas LV; Amador-Sánchez R; Espinosa-Elizondo RM; Martín-Trejo JA; Velázquez-Aviña MM; Merino-Pasaye LE; Pérez-Saldívar ML; Duarte-Rodríguez DA; Torres-Nava JR; Cortés-Herrera B; Solís-Labastida KA; González-Ávila AI; Santillán-Juárez JD; García-Velázquez AJ; Rosas-Vargas H; Mata-Rocha M; Sepúlveda-Robles OA; Mejía-Aranguré JM; Jiménez-Morales S
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183133
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
Levinsen M; Taskinen M; Abrahamsson J; Forestier E; Frandsen TL; Harila-Saari A; Heyman M; Jonsson OG; Lähteenmäki PM; Lausen B; Vaitkevičienė G; Asberg A; Schmiegelow K;
Pediatr Blood Cancer; 2014 Aug; 61(8):1416-21. PubMed ID: 24623619
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia.
Jastaniah W; Elimam N; Abdalla K; AlAzmi AA; Algamal A; Felimban S
Hematology; 2019 Dec; 24(1):369-377. PubMed ID: 30885098
[TBL] [Abstract][Full Text] [Related]
9. Development of an immune-related prognostic model for pediatric acute lymphoblastic leukemia patients.
Quan X; Zhang N; Chen Y; Zeng H; Deng J
Mol Genet Genomic Med; 2020 Sep; 8(9):e1404. PubMed ID: 32666718
[TBL] [Abstract][Full Text] [Related]
10. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
11. CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study.
Jacoby E; Ghorashian S; Vormoor B; De Moerloose B; Bodmer N; Molostova O; Yanir AD; Buechner J; Elhasid R; Bielorai B; Rogosic S; Dourthe ME; Maschan M; Rossig C; Toren A; von Stackelberg A; Locatelli F; Bader P; Zimmermann M; Bourquin JP; Baruchel A
Leukemia; 2022 Jun; 36(6):1525-1532. PubMed ID: 35468946
[TBL] [Abstract][Full Text] [Related]
12. Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimäki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
Pediatr Blood Cancer; 2022 Jul; 69(7):e29745. PubMed ID: 35488712
[TBL] [Abstract][Full Text] [Related]
13. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia.
Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y
Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features.
Zhang X; Lu XA; Yang J; Zhang G; Li J; Song L; Su Y; Shi Y; Zhang M; He J; Song D; Lv F; Li W; Wu Y; Wang H; Liu H; Zhou X; He T; Lu P
Blood Adv; 2020 May; 4(10):2325-2338. PubMed ID: 32453841
[TBL] [Abstract][Full Text] [Related]
15. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
[TBL] [Abstract][Full Text] [Related]
16. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for childhood acute lymphoblastic leukemia.
Chen Z; Yang F; Liu H; Fan F; Lin Y; Zhou J; Cai Y; Zhang X; Wu Y; Mao R; Zhang T
Aging (Albany NY); 2021 Jun; 13(11):15548-15568. PubMed ID: 34106877
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.
Thastrup M; Marquart HV; Levinsen M; Grell K; Abrahamsson J; Albertsen BK; Frandsen TL; Harila-Saari A; Lähteenmäki PM; Niinimäki R; Pronk CJ; Ulvmoen A; Vaitkevičienė G; Taskinen M; Schmiegelow K;
Leukemia; 2020 Feb; 34(2):336-346. PubMed ID: 31534171
[TBL] [Abstract][Full Text] [Related]
18. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.
Gu R; Liu F; Zou D; Xu Y; Lu Y; Liu B; Liu W; Chen X; Liu K; Guo Y; Gong X; Lv R; Chen X; Zhou C; Zhong M; Wang H; Wei H; Mi Y; Qiu L; Lv L; Wang M; Wang Y; Zhu X; Wang J
J Hematol Oncol; 2020 Sep; 13(1):122. PubMed ID: 32894185
[TBL] [Abstract][Full Text] [Related]
20. Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel.
Ravich JW; Huang S; Zhou Y; Brown P; Pui CH; Inaba H; Cheng C; Gottschalk S; Triplett BM; Bonifant CL; Talleur AC
Transplant Cell Ther; 2022 Feb; 28(2):73.e1-73.e9. PubMed ID: 34875402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
